Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Startups say permitting, zoning and lack of local CMOs push medtech manufacturing out of California
Summary
A Y Combinator‑backed founder told the Assembly committee that permitting timelines, zoning and thin local contract manufacturing capacity make California less viable for scaling medtech manufacturing, and asked the committee to streamline permits and offer incentives.
Lucas Springer, CEO of Newman, told the Assembly Select Committee on Biotechnology and Medical Technology that early‑stage companies face specific and practical barriers to manufacturing in California that differ from the challenges of raising R&D capital.
"Permitting timelines can stretch for years. Zoning restrictions... make it difficult…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
